Key Account Manager, Rare Diseases - Endocrinology (Małopolska or Śląsk)

Job Purpose

Preferred place of residence: Małopolskie or Śląskie voivodeship

Territory: Śląskie, Małopolskie, Świętokrzyskie, Podkarpackie

The Key Account Manager is responsible for driving sales growth and maximizing business opportunities for the Recordati Rare Diseases Endocrinology portfolio within the assigned territory.

Key Responsibilities

• Implement sales and marketing strategies for the assigned Endocrinology portfolio within the region.
• Achieve sales targets and KPIs.
• Develop relationships with endocrinologists, oncologists, KOLs, pharmacists and key stakeholders.
• Promote products through face-to-face and omnichannel engagement.
• Organize scientific meetings, webinars and congress activities.
• Monitor market trends and competitor activities.
• Manage territory plans and reporting requirements.

Required Education

• University degree in Life Sciences, Pharmacy, Medicine, or related field.

Required Skills and Experience

• 3–5 years of pharmaceutical industry experience.
• Experience in rare diseases, endocrinology, and/or oncology will be an additional asset.
• Experience working with KOLs and specialist physicians.
• Knowledge of the Polish healthcare system and hospital environment.

Required Behaviours and Competencies

• Commercial mindset and business acumen.
• Excellent communication and presentation skills.
• Strong relationship-building and organizational skills.
• Self-motivated and results-oriented approach.

Required Languages

• Fluent Polish.
• Communicative level of English.

Travel required in %

• Frequent travel within the assigned territory (up to 70%).

By joining us, you will gain:

• Stable employment based on a full-time contract.
• Task-based and flexible work organization.
• Essential work tools (mobile phone, laptop, and company car)
• Private healthcare, life insurance, lunch card and wellbeing platform.
• Opportunity to benefit from additional social fund programs, including vacation subsidies and Multisport co-financing.